LOCALIZATION OF THE LEFT VENTRICULAR MYOCARDIAL SCARRING AND ITS ELECTRICAL ACTIVATION IN PATIENTS WITH HEART FAILURE AND DIFFERENT RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY

Introduction. As a significant number of patients with heart failure (HF) does not respond to cardiac resynchronization therapy (CRT), a lot of research has deservedly focused on optimization, and better patient selection. The ideal resynchronization depends on different factors, from device programming to heart features and left ventricle (LV) lead position. Analysis of the 12-lead electrocardiogram (ECG) is the most simple method which can provide important information on LV lead location, presence of scar at LV pacing site, and fusion of intrinsic activation or RV pacing with LV pacing.

Purpose. To analyze the electrophysiological and structural heart features and their correlation with the ECG pattern during biventricular (BV) pacing in patients with HF and CRT devices.

Methods. The study included 47 patients (mean age 62.3±8.9 years) with LBBB, QRS duration ≥ 130 ms, left ventricular ejection fraction (LVEF) ≤ 35%, heart failure (HF) NYHA II-IV despite optimal pharmacological therapy during months. All patients had undergone CRT-D implantation. Late-gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR), 12-lead ECG, non-invasive cardiac mapping (NICM) (with obtaining the zone of late LV activation (ZLA)) were undertaken prior to CRT devices implantation. NICM with cardiac CT and evaluation of LV lead position, ECG pattern during BV pacing (#1 - fusion complex with increased or dominant R wave, independent of QRS duration, #2- QS pattern with QRS duration normalization, and #3- QS pattern with increased QRS duration) were undertaken after CRT devices implantation. Response to CRT was estimated by echo and was defined as decrease in LV end-systolic volume by > 15% after 6 months of follow-up.

Results. CRT was effective in 28 patients (59.5%). According to the results of NICM, zone of late LV activation more often was located at 5,6,11,12 segments, and LV pacing site - at 6,7,12 segments of LV. In the “response” group overlap of scar zone and zone of late LV activation was observed (p=0.005). The presence of scar tissue in the LV pacing site was associated with CRT non-response (p<0.001), and the pacing zone of late LV activation resulted in the best CRT response (p<0.001). The distance from the LV electrode to the zone of late LV activation was less in the “CRT response” group (33 [20;42] mm vs 83 [55;100] mm, p<0.001). The most beneficial ECG pattern during BV pacing was #2, and #3 was more often observed in the group “CRT non-response”; configuration #1 was intermediate between ECG patterns #2 and #3.

Conclusions. A comprehensive examination, including the study of the structural and electrophysiological heart features is important for the optimal positioning the LV lead and subsequent CRT device programming. The simple analysis of the QRS pattern during BV pacing can show whether biventricular pacing is adequately performed and can reveal inadequate CRT programming and LV lead positioning.

1. Petersen S, Rayner M, Wolstenholme J. Coronary Heart Disease Statistics, Heart Failure Supplement, June 2002, British Heart Foundation.

2. Padelettia L., Giaccardia M., Turrenia F., et al. Infl uence of QRS prolongation on the natural history of CHF // European Heart Journal Supplements.2004; 6 (Supplement D): D79-D82.

3. Tabrizi F., Englund A., Rosenqvist M., et al. Influence of left bundle branch block on long-term mortality in a population with heart failure // European Heart Journal.2007;28: 2449-2455.

4. Барт Б. Я., Ларина В. Н., Бродский М. С. Ремоделирование сердца и прогноз больных с хронической сердечной недостаточностью при наличии полной блокады левой ножки пучка Гиса // Российский кардиологический журнал. 2011;6: 4-8 [Bart B.Ya, Larina V.N, Brodskyi M.S. Cardiac remodeling and clinical prognosis in patient with chronic heart failure and complete left bundle branch block // Russ J Cardiol. 2011;6: 4-8 (in Russ.)].

5. Cazeau S., Ritter P., Bakdach S. et al. Four Chamber Pacing in Dilated Cardiomyopathy // PACE. 1994; 17(Pt. II):1974-1979.

6. McAlister F.A., Ezekowitz J.A., et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure // Ann Intern Med. 2004 Sep 7;141(5):381- 90. Epub 2004 Aug 16.

7. Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure // N Engl J Med. 2005; 352:1539-1549.

8. Yu C.M., Bleeker G.B., Fung J.W-H., et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy // Circulation. 2005; 112:1580-1586.

9. Ypenburg C., Van De Veire N., Westenberg J.J., et al. Noninvasive imaging in cardiac resynchronization therapy. Part 2: Follow- up and optimization of settings // Pacing Clin. Electrophysiol. 2008; Vol. 31(12): 1628-1639.

10. Bleeker G.B., Schalij M.J., Van der Wall E.E., et al. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy // J. Cardiovasc. Electrophysiol. 2006; Vol. 17(8): 899-901.

11. Wilton S.B., Shibata M.A., Sondergaard R. et al. Relationship between left ventricular lead position using a simple radiographic classifi cation scheme and long-term outcome with resynchronization therapy // J. Interv. Card. Electrophysiol. 2008; Vol. 23(3): 219-227.

12. Polasek R, Kucera P, Nedbal P., et al. Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up // BMC Cardiovasc Disord. 2012;12:34.

13. Leyva F, Foley PWX, Chalil S et al. Cardiac resynchronisation therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance // J Cardiovasc Magn Reson. 2011; 13: 29-35.

14. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Eff ect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy // Circulation.2006; 113: 969-76.

15. Adelstein E., Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy // Am Heart J.2007; 153: 105-12.

16. Зубарев С.В., Чмелевский М.П., Буданова М.А. и др. Совершенствование методики поверхностного неинвазивного эпи- и эндокардиального картирования при нарушениях внутрижелудочковой проводимости // Вестник Аритмологии. 2015: 80; 42-48. [Zubarev S.V., Chmelevsky M.P., Budanova M.A., et al. Improving noninvasive methodology of surface epi-and endocardial mapping in patients with impaired intraventricular conduction // Journal of arrhythmology. 2015: 80; 42-48 (in Russ.)].

17. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН) // Сердечная недостаточность. 2017;18 (1):3-40. [Mareev V.Yu., Fomin I.V., Ageev F.T. et al. Clinical guidelines. Chronic heart failure (CHF) // Russian Heart Failure Journal. 2017;18 (1):3-40 (in Russ.)].

18. Ponikowski, P., Voors, A. A., Anker, S. D., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // European Heart Journal. 2016; 37(27): 2129-2200.

19. Biton Y, Kutyifa V, Zareba W et al. Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT // Heart Fail. Rev. 2015; 20(5): 535-543.

20. Kutyifa, V, Goldenberg I, Moss A. Lessons learned from the Multicenter Automatic Defi brillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) // Trends. Cardiovasc. Med. 2016; 26(2): 137- 146.

21. Leclercq C., Kass D. Retiming the failing heart: principles and current status of cardiac resynchronization // J Am Coll Cardiol. 2002; 39: 194 -201.

22. Rahmouni H.W., Kirkpatrick J.N., St. John Sutton M.G. Eff ects of cardiac resynchronization therapy on ventricular remodeling / // Curr. Heart Fail. Rep. 2008; 5 (1): 25-30.

23. Ypenburg C., Roes S. Bleeker G., et al. Eff ect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy // Am J Cardiol. 2007; 99(5): 657-660.

24. Chalil S., Foley P., Muyhaldeen S., et al. Late gadolinium enhancement cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy // Europace. 2007; 9: 1031-1037.

25. El-Sherif N., Hope R.R, Scherlag B.J, Lazzara R. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 2. Patterns of initiation and termination of re-entry // Circulation. 1977; 55(5): 702-719.

26. Каштанова С.Ю., Миронова Н.А., Шитов В.Н. и др. Комплексная оценка электрокардиографических и эхокардиографических параметров у больных с блокадой левой ножки пучка Гиса в прогнозировании успеха сердечной ресинхронизирующей терапии // Терапевтический архив. 2018; 12: 76-83. [Kashtanova S.Yu., Mironova N.A., Shitov V.N., et al. Role of electrocardiographic and echocardiographic types of left bundle branch block in prediction of response to cardiac resynchronization therapy // Therapeutic archive. 2018; 12: 76-83 (in Russ.)].

27. Каштанова С.Ю., Миронова Н.А., Гупало Е.М. и др. Оценка электрической диссинхронии миокарда с помощью неинвазивного активационного картирования и ее роль в достижении успеха проведения сердечной ресинхронизирующей терапии // Кардиология. 2019; 59 (4): 21-32. [Kashtanova S.Yu., Mironova N.A., Gupalo E.M. Assessment of myocardial electrical dissynchrony by noninvasive activation mapping and its role in achieving the success of cardiac resynchronization // Kardiologiia. 2019; 59 (4): 21-32 (in Russ.)].

28. Ypenburg C., Van Bommel R.J., Delgado V. et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy // J. Am. Coll. Cardiol. 2008; 52(17): 1402- 1409.

29. Stankovic I., Aarones M., Smith H.J. et al. Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy // Eur. Heart J. 2014; 35 (1): 48-55.

30. Blendea D., Singh J.P. Lead positioning strategies to enhance response to cardiac resynchronization therapy // Heart Fail. Rev. 2011; 16: 291- 303.

31. Khan F.Z., Virdee M.S., Palmer C.R. et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial // J. Am. Coll. Cardiol. 2012; 59 (17): 1509-1518

32. Rad M, Blaauw Yu., Dinh T., et al. Left ventricular lead placement in the latest activated region guided by coronary venous electroanatomic mapping // EP Europace. 2015; 17 (1): 84-93.